Tuesday, December 23, 2014

Alder Biopharmaceuticals Seeks $115M More On Markets

Bothell-based Alder Biopharmaceuticals said in a filing Monday that it is looking to raise another $115M on the markets, via a secondary stock offering. Alder went public on the NASDAQ as ALDR in May. The new stock offering is being underwritten by Credit Suisse, Leerink Partners, Wells Fargo Securities, and Sanford C. Bernstein.